Previous 10 | Next 10 |
SARASOTA, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the “Notice”) from the NYSE American LL...
A look at the top 10 most actives in the United States Akoustis Technologies Inc. (AKTS) rose 254.9% to $0.4887 on volume of 265,314,772 shares Greenwave Technology Solutions Inc. (GWAV) rose 2.9% to $0.0606 on volume of 147,993,224 shares Crown Electrokinetics Corp. (CRKN) fell 17.8% to ...
2024-05-22 10:00:31 ET More on etc. Replimune: Continuing To Justify The Bear Thesis (For Now) Gold At $3,000 Is The Wrong Way To Think About The Precious Metal Best Buy: Poised For Growth Amid E-Commerce Threat Nvidia’s upcoming earnings has investors...
SARASOTA, Fla., May 22, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced it has appointed Dr. William “Frank” Peacock as its Chief Clinical ...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 37.1% to $0.2344 on volume of 300,511,226 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 78.2% to $1.835 on volume of 218,102,513 shares Greenwave Technology Solutions Inc. (GWAV) r...
2024-05-17 14:15:35 ET More on Mid-day movers & stocks. Broadwind, Inc. (BWEN) Q1 2024 Earnings Call Transcript Broadwind, Inc. 2024 Q1 - Results - Earnings Call Presentation Broadwind, Inc. (BWEN) Q4 2023 Earnings Call Transcript Oragenics climbs 9% amid...
SARASOTA, Fla., May 17, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering pharmaceutical company specializing in intranasal treatments for neurological disorders, today announced that the company will host a webinar panel on Neurotrauma Medicine Monday, May 20, 2024, at...
2024-05-16 10:48:58 ET More on Oragenics Oragenics files 10K and provides company update Oragenics stock dips after pricing $2.1M stock offering Financial information for Oragenics Read the full article on Seeking Alpha For further details see: Or...
SARASOTA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering pharmaceutical company specializing in intranasal treatments for neurological disorders, today announced an update on the company and its drug development program. Oragenics is designing an upcomi...
2024-05-13 13:30:51 ET More on mid-day movers & stocks. CareCloud, Inc. (CCLD) Q4 2023 Earnings Call Transcript Faraday Future announces Nasdaq delisting determination Faraday Future Intelligent Electric receives Nasdaq non-compliance letter Seeking Alpha...
News, Short Squeeze, Breakout and More Instantly...
SARASOTA, Fla., July 10, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced it has developed a new formulation for its novel neurosteroid. Oragenics’...
SARASOTA, Fla., June 27, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced it has completed a prototype of its automated intranasal device for use in concu...